Unilever PLC (LSE:ULVR), Nestlé India Limited (BSE:500790) and Coca-Cola India Private Limited have begun due diligence on GlaxoSmithKline Consumer Healthcare Limited (BSE:500676) which includes Horlicks and Boost, and is estimated to be worth about $4 billion, three people aware of the developments said. Spokespersons at HUL, Nestle and Coca-Cola said they wouldnot comment on speculation'.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4,314 GBX | 0.00% | +2.45% | +13.55% |
May. 13 | Ben & Jerry's board says pro-Palestinian campus protests are 'essential' to democracy | RE |
May. 13 | Unilever: honored for its marketing creativity | CF |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+13.55% | 136B | |
+13.19% | 391B | |
+18.50% | 77.5B | |
-11.43% | 66.4B | |
-7.89% | 48.3B | |
-5.43% | 38.99B | |
+8.44% | 35.51B | |
+12.88% | 18.18B | |
+15.63% | 16.39B | |
+0.62% | 11.68B |
- Stock Market
- Equities
- ULVR Stock
- News Unilever PLC
- Unilever, Nestle And Coca-Cola Reportedly Begin Due Diligence On Glaxosmithkline Consumer Healthcare